Deccan Health Care Limited Announces Strong Financial Performance For Q2 and H1 FY 2025-26

Sustained Growth Momentum with Expanding Market Reach and Strengthened Profitability

India, November 17, 2025: Deccan Health Care Limited (DHCL) has reported a significant operational and financial performance for the quarter and half-year ended 30 September 2025, demonstrating the company’s robust revenue growth trajectory, healthy profitability and strategic focus on innovation-led, preventive healthcare solutions.

Financial Performance Overview

The company delivered significant operational performance across key metrics, showing clear momentum driven by strong product innovation acceptance, product lines expansion, and operational efficiency.

• Revenue from Operations:

• • Standalone: 

• • • Quarter Performance: ₹2,440.46 lakh – Growth: +29.7% YoY
    • Half-Year Performance: ₹4,587.41 lakh – Growth: +35.4% YoY

• Consolidated:
  • Quarter Performance: ₹2,139.56 lakh
  • Half-Year Performance: ₹4,353.58 lakh

• Net Profit:

• • Standalone: 

• • • Quarterly PAT: ₹89.97 lakh – Up: 67.5% YoY
    • Half-Year PAT: ₹111.22 lakh – Up: 22.8% YoY

• Consolidated:
  • Quarterly PAT: ₹91.40 lakh
  • Half-Year PAT: ₹115.11 lakh

The results show:

• EPS steady and improving, signalling value accretion
• Equity Base Strengthened through share conversions
• Zero investor complaints – strong governance

These results reflect a company in strong forward momentum, driven by strengthening fundamentals, expanding market reach, and rising profitability. Deccan Health Care Ltd. continues to create long-term value for its shareholders through consistent growth, operational discipline, and a steadfast focus on innovation.

In line with its strategic plan, DHCL has broadened its wellness portfolio with innovative launches such as EnergyDecc™️, SlimDecc™️, Reactive Go Advanced, and a new range of functional fruit bars and gummies. The company has also introduced its pioneering Weight Wellness Program—an integrated, science-backed approach to achieving and maintaining an ideal body weight with sustained energy, strength, and balance. Unlike conventional short-term weight loss methods, this program focuses on metabolic balance, vitality, and holistic well-being through three synergistic formulations. Together, these innovations empower individuals to “Shape and Energize the Body Naturally”—without crash diets, stimulants, or side effects.

Alongside its domestic growth, DHCL continues to expand its global footprint, with regulatory filings completed in six international markets and product launches in the UAE and GCC planned for March 2026.

Commenting on the performance, Mr Mohak from Deccan Health Care said:
“Our Q2 performance demonstrates the resilience of our model and rising consumer preference for preventive, scientific wellness. We remain focused on disciplined execution, export-readiness, and sustained long-term value creation.”

For Media & Investor Enquiries: [email protected]

Safe Harbour Statement:
Statements in this release relating to future performance are forward-looking and subject to risks and uncertainties that could cause actual results to differ materially, including economic conditions, regulatory approvals, competitive dynamics, supply chain disruptions, and market shifts.